Protein name:
Interleukin-31 (IL-31) ;
Alternative:
Organism:
Human (Homo sapiens).
General Annotation
Function:
Activates STAT3 and possibly STAT1 and STAT5 through the IL31 heterodimeric receptor composed of IL31RA and OSMR. IL31 may function in skin immunity.
Subcellular Location:
Secreted
Protein Attributes:
50:
MASHSGPSTS | VLFLFCCLGG | WLASHTLPVR | LLRPSDDVQK | IVEELQSLSK |
100:
MLLKDVEEEK | GVLVSQNYTL | PCLSPDAQPP | NNIHSPAIRA | YLKTIRQLDN |
150:
KSVIDEIIEH | LDKLIFQDAP | ETNISVPTDT | HECKRFILTI | SQQFSECMDL |
Vaild Sequence:
Related Databases
Uniprot:
ELISA Kit
CLIA Kit
Polyclonal Antibody
Monoclonal Antibody
Protein
FOR
Human
Mouse
ELISA Kit for Human IL-31
ELISA Kit for Human IL-31
Polyclonal Antibody for Human IL-31
Polyclonal Antibody for Human IL-31
Monoclonal Antibody for Human IL-31
Monoclonal Antibody for Human IL-31
R&D Technical Data
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Precision
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Recovery
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Linearity
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
Citations
[1].
K Siniewicz-Luzeńczyk, A Stańczyk-Przyłuska, K Zeman.
References
1.
"Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice."
Dillon S.R.
,
Sprecher C.
,
Hammond A.
,
Bilsborough J.
,
Rosenfeld-Franklin M.
,
Presnell S.R.
,
Haugen H.S.
,
Maurer M.
,
Harder B.
,
Johnston J.
,
Bort S.
,
Mudri S.
,
Kuijper J.L.
,
Bukowski T.
,
Shea P.
,
Dong D.L.
,
Dasovich M.
,
Grant F.J.
,
Lockwood L.
,
Levin S.D.
,
LeCiel C.
,
Waggie K.
,
Day H.
,
Topouzis S.
,
Kramer J.
,
Kuestner R.
,
Chen Z.
,
Foster D.
,
Parrish-Novak J.
,
Gross J.A.
more...
Nat. Immunol.5:752-760(2004)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [MRNA];FUNCTION;TISSUE SPECIFICITY
tissue :
Peripheral blood .
2.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]
3.
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : INDUCTION
4.
"Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis."
Neis M.M.
,
Peters B.
,
Dreuw A.
,
Wenzel J.
,
Bieber T.
,
Mauch C.
,
Krieg T.
,
Stanzel S.
,
Heinrich P.C.
,
Merk H.F.
,
Bosio A.
,
Baron J.M.
,
Hermanns H.M.
J. Allergy Clin. Immunol.118:930-937(2006)
[
PubMed ]
[
Europe PMC ]
[
Abstract ]
[15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s)
Cited for : INDUCTION